In patients with moderate- and high-risk acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI), the Syntax score predicts 1-year ischemic outcomes including mortality, ...

The 3-year results of the SYNTAX trial, according to data presented by Patrick W. Serruys, MD, PhD, suggested that percutaneous coronary intervention is a reasonable alternative to CABG for patients ...

The extent and severity of disease, as assessed by Syntax score, strongly correlates with the risk of stent thrombosis at 30 days and 1 year in patients with non-ST-segment elevation acute coronary ...

September 13, 2010 (Geneva, Switzerland) — Three-year results for the landmark SYNTAX trial are bringing some clarity to a finding just hinted at--then strenuously debated--at the two-year mark: ...

Please provide your email address to receive an email when new articles are posted on . At 5 years, elevated rates of major CV events were found in patients with diabetes and stable ischemic heart ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PARIS -- With ...

Coronary artery bypass grafting (CABG) should remain the "standard of care" for patients with complex coronary artery disease, concludes the SYNTAX study, published in the New England Journal of ...

The SYNTAX score is an anatomical-based tool that has quickly become established for long-term risk prediction after percutaneous coronary intervention (PCI). Since publication of the SYNTAX trial, Dr ...

BARCELONA — Final, five-year results from the SYNTAX trial comparing CABG surgery and PCI with a drug-eluting stent (DES) in patients with complex coronary disease confirm the message that started to ...